DESCOVY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Emtricitabine; Tenofovir Alafenamide Fumarate.
| Product ID | 61958-2002_3280d94c-8145-478d-b718-91358fdca9de | 
| NDC | 61958-2002 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | DESCOVY | 
| Generic Name | Emtricitabine And Tenofovir Alafenamide | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2016-04-04 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA208215 | 
| Labeler Name | Gilead Sciences, Inc. | 
| Substance Name | EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | 
| Active Ingredient Strength | 200 mg/1; mg/1 | 
| Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2016-04-04 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA208215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-01-22 | 
| Marketing Category | NDA | 
| Application Number | NDA208215 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2016-04-04 | 
| Ingredient | Strength | 
|---|---|
| EMTRICITABINE | 200 mg/1 | 
| SPL SET ID: | 06f66e98-e6ee-4538-9506-6c1282cc14c1 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 61958-2002 | DESCOVY | emtricitabine and tenofovir alafenamide | 
| 61958-2005 | DESCOVY | emtricitabine and tenofovir alafenamide | 
| 70518-0230 | DESCOVY | emtricitabine and tenofovir alafenamide fumarate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  DESCOVY  86170326  4876632 Live/Registered | Gilead Sciences Ireland UC 2014-01-20 |